COVID antibody test in German town shows 15 percent infection rate
This morning we have some data giving a little more insight into the great unknown of the coronavirus pandemic: just how widely among the population has SARS-CoV-2 — the virus which causes COVID-19 — spread among the general population. A team at the University of Bonn has tested a randomized sample of 1,000 residents of the town of Gangelt in the north-west of the country, one of the epicenters of the outbreak in Germany. The study found that two percent of the population currently had the virus and that 14 percent were carrying antibodies suggesting that they had already been infected — whether or not they experienced any symptoms. Eliminating an overlap between the two groups, the team concluded that 15 percent of the town has been infected with the virus.
This number matters hugely because it tells us what we need to know in order to judge how deadly the virus is and also how easily it spreads. It tells us, ultimately, how useful the methods are that we are employing in order to combat the virus. As explained here before, the question of how many people already have the infection is at the heart of a debate between epidemiologists at the Imperial College and Oxford University.
Two weeks ago, the latter published modeling claiming that up to half the UK population might already have been infected with the virus — a level of infection which would mean that lockdown may be the wrong approach, as we would already have achieved a state of herd immunity, preventing the further spread of the disease.
The Gangelt study does not provide support for the idea that half of the population of Britain, or any other country, has been infected with the virus. But for a town to have an infection rate of 15 percent suggests that the virus had spread a lot further than many believed. Neil Ferguson, who leads the Imperial team, told the FT this week that he believes between three and five percent of the UK population has already been infected.
Data from coronavirus deaths in Gangelt suggests an infection mortality rate of 0.37 percent, significantly below the 0.9 percent which Imperial College has estimated, or the 0.66 percent found in a revised study last week.
The 15 percent figure from Gangelt is interesting because it matches two previous studies. Firstly, there was the accidental experiment of the cruise ship the Diamond Princess, which inadvertently became a floating laboratory when a passenger showing symptoms of COVID-19 boarded on January 20 and remained in the ship, spreading the virus, for five days. The ship was eventually quarantined on February 3 and all its 3,711 passengers tested for the virus. It turned out the 634 of them — 17 percent — had been infected, many of them without symptoms. The mortality rate on the vessel was 1.2 percent — although, inevitably being a cruise ship, it was a relatively elderly cohort.
We gained another insight into SARS-CoV-2 from a Chinese study into 391 cases of COVID-19 in the southern Chinese city of Shenzhen. In this case, scientists tested everyone who shared a household with people who were found to be suffering from the disease. It turned out 15 percent of this group had gone on to be infected with SARS-CoV-2 themselves. Again, many showed no symptoms.
Obviously these are all small-scale studies and none of them are deliberate experiments to see how far SARS-CoV-2 will spread if it is allowed to ‘rip through’ a population. But they do raise the question: is there a ceiling on the number of people who are prone to be infected with the disease? Do many of us have some kind of natural protection against infection? Would it ever spread among more than about one in six of us?
The British government has based its planning and policy for COVID-19 on the assumption that if the virus was allowed to spread unchecked it would eventually infect 80 percent of the population. That is a figure that seems to have been borrowed from planning for a flu pandemic, but that doesn’t necessarily mean it applies to this virus. The sooner we have the results of more studies like that at Gangelt, the better a picture we have and the sooner we will be able to plot a path out of lockdown.
Antibody, COVID, Germany. Antibody, COVID, Germany. Antibody, COVID, Germany. Antibody, COVID, Germany.
This article was originally published on The Spectator’s UK website.
Solemnly Declare: The copyright of this article belongs to the original author. The reprinted article is only for the purpose of disseminating more information. If the author’s information is marked incorrectly, please contact us as soon as possible to modify or delete it.